pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 3
allantoin
Zorblisa (allantoin)
Epidermolysis Bullosa
Paradigm Therapeutics Inc
0
catalysts
Marketed
allopurinol
Zyloprim (allopurinol)
Kidney Disease (Nephropathy)
Casper Pharma LLC
0
catalysts
Marketed
almotriptan malate
Almotriptan (almotriptan malate)
Migraine
Ajanta Pharma USA Inc
0
catalysts
Phase 2
← prev
page 153 of 231
next →
131
Pain
89
Neurology
1
alnodesertib
alnodesertib [INN]
Metastatic Colorectal Cancer
Artios Pharma Ltd
0
catalysts
Phase 2
alogabat
Autism Spectrum Disorder (ASD)
F. Hoffmann-La Roche Ltd
0
catalysts
Marketed
alogliptin benzoate
Alogliptin Benzoate Perrigo (alogliptin benzoate)
Type 2 Diabetes
Perrigo New York Inc
0
catalysts
Marketed
alosetron hydrochloride
Lotronex (alosetron hydrochloride)
Irritable Bowel Syndrome
Sebela Pharmaceuticals Inc
0
catalysts
Marketed
alpelisib
Piqray (alpelisib)
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
$NVS
NOVARTIS AG
0
catalysts
Phase 2
alpha-1 proteinase inhibitor (human)
Prolastin (alpha-1 proteinase inhibitor (human))
Lung Transplant Rejection
Neutrophil elastase
$TAK
TAKEDA PHARMACEUTICAL CO LTD
0
catalysts
Preclinical
alphaxalone
alphaxalone [INN]
Anesthetic Effect
Cali Biosciences Co Ltd
0
catalysts
Marketed
alprazolam ER
Alprazolam (alprazolam)
Panic Disorders
$AMRX
Amneal Pharmaceuticals, Inc.
0
catalysts
Phase 2
alrizomadlin
alrizomadlin [INN]
Lung Adenocarcinoma
$AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
0
catalysts
Marketed
alteplase
Activase (alteplase)
Acute Ischemic Stroke
Genentech Inc
0
catalysts
Phase 2
alvelestat
alvelestat [INN]
Alpha-1 Antitrypsin Deficiency (A1AD)
$MREO
Mereo BioPharma Group plc
0
catalysts
Marketed
amantadine hydrochloride ER
Gocovri (amantadine hydrochloride)
Dyskinesia
Adamas Pharmaceuticals Inc
0
catalysts
Marketed
amcinonide
Amcinonide (amcinonide)
Psoriasis
Solubiomix LLC
0
catalysts
Marketed
amdinocillin pivoxil
Pivya (amdinocillin pivoxil)
Urinary Tract Infections
Alembic Pharmaceuticals Inc
0
catalysts
Phase 2
ametefgene parvec
ametefgene parvec [INN]
Parkinson's Disease
Asklepios BioPharmaceutical Inc
0
catalysts
Phase 2
amezalpat
amezalpat [INN]
Metastatic Hepatocellular Carcinoma (HCC)
$TPST
Tempest Therapeutics, Inc.
0
catalysts
Phase 2
amezosvatein
amezosvatein [INN]
Herpes Zoster (Shingles)
Curevo Inc
0
catalysts
Marketed
amifampridine
Amifampridine (amifampridine)
Lambert–Eaton Myasthenic Syndrome (LEMS)
Lupin Ltd
0
catalysts
Marketed
amifampridine phosphate
Firdapse (amifampridine phosphate)
Lambert–Eaton Myasthenic Syndrome (LEMS)
$CPRX
CATALYST PHARMACEUTICALS, INC.
0
catalysts
Preclinical
amifostine
Radiation Injury
F3 Platform Biologics Inc
0
catalysts
Marketed
amiloride hydrochloride
Amiloride Hydrochloride (amiloride hydrochloride)
Congestive Heart Failure (Heart Failure)
Endo Pharmaceuticals Inc
0
catalysts
Marketed
aminolevulinic acid hydrochloride
Ameluz (aminolevulinic acid hydrochloride)
Basal Cell Carcinoma (Basal Cell Epithelioma)
$BFRI
Biofrontera Inc.
0
catalysts
Marketed
amiodarone hydrochloride
Amiodarone Hydrochloride (amiodarone hydrochloride)
Ventricular Arrhythmia
Taro Pharmaceutical Laboratories Inc (Inactive)
0
catalysts
Phase 2
amiselimod hydrochloride
Ulcerative Colitis
Sphingosine 1-phosphate receptor
Salix Pharmaceuticals Ltd
0
catalysts
Marketed
amisulpride
Barhemsys (amisulpride [INN])
Chemotherapy Induced Nausea and Vomiting
Acacia Pharma Group Ltd
0
catalysts
Phase 2
amitriptyline hydrochloride
Amitriptyline Hydrochloride (amitriptyline hydrochloride)
Chemotherapy Induced Peripheral Neuropathy
Sodium-dependent noradrenaline transporter
Sodium-dependent serotonin transporter
AlgoTherapeutix SAS
0
catalysts
Phase 3
amlenetug
Multiple System Atrophy (Multi-System Degeneration)
H. Lundbeck AS
0
catalysts
